Orion Corporation competitive analysis

Explore patent oppositions filed by Orion Corporation against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 10, 2026
Patent NumberTitleApplicantOpposition Date
Pharmaceutical Composition Containing Glycopyrrolate And A Beta2 Adrenoceptor AgonistNOVARTISSep 11, 2020

Explore Orion Corporation's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 10, 2026
Patent NumberPublication DateTitleTotal Oppositions
Apr 9, 2025Manufacture Of A Crystalline Pharmaceutical Product7
May 18, 2022A Carboxamide Derivative And Its Diastereomers In Stable Crystalline Form1
Feb 26, 2020Process For The Preparation Of Androgen Receptor Antagonists And Intermediates Thereof1

Latest PTAB cases involving Orion Corporation

Discover the latest PTAB cases involving Orion Corporation, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Orion Corporation with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 10, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ORION - 8 - -
DR. SCHNEIDER KUNSTSTOFFWERKE GMBH313 - -
DR. SCHÖN, NEYMEYR & PARTNER PATENTANWÄLTE MBB35 - - -
HAMM&WITTKOPP PATENTANWÄLTE PARTMBB82 - - -